Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of PL-5 spray for secondary wound infection
ChiCTR2000033334Phase 2Not yet recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Jun 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label trial of peceleganan in Wound infection (WI) (4 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoint: Clinical efficacy on day 1 after last administration. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
peceleganan
03
Conditions
Wound infection (WI)
Beyond the preview
Go deeper on ChiCTR2000033334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033334.